The share of scientific publications involving international collaboration in drug discovery in the US is expected to experience a steady increase from 32.57% in 2024 to 35.92% in 2028. Assuming a consistent trend from 2023, the data indicates a positive upward trajectory, with year-on-year variations showing a modest but steady growth. The compound annual growth rate (CAGR) over five years appears promising as it reflects an ongoing rise, suggesting an increasing global interconnectedness in drug discovery research.
Future trends to watch for include:
- The impact of policy changes on international collaboration.
- Technological advancements facilitating cross-border research partnerships.
- Potential increases in funding for international collaborative projects.
